DK116020B - Fremgangsmåde til fremstilling af farmaceutiske granulater, tabletter eller kapsler indeholdende antacidium, fyldstof og organopolysiloxan. - Google Patents

Fremgangsmåde til fremstilling af farmaceutiske granulater, tabletter eller kapsler indeholdende antacidium, fyldstof og organopolysiloxan.

Info

Publication number
DK116020B
DK116020B DK612766AA DK612766A DK116020B DK 116020 B DK116020 B DK 116020B DK 612766A A DK612766A A DK 612766AA DK 612766 A DK612766 A DK 612766A DK 116020 B DK116020 B DK 116020B
Authority
DK
Denmark
Prior art keywords
antacidium
organopolysiloxane
tablets
filler
preparation
Prior art date
Application number
DK612766AA
Other languages
English (en)
Inventor
J Yen
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of DK116020B publication Critical patent/DK116020B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/80Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D19/00Degasification of liquids
    • B01D19/02Foam dispersion or prevention
    • B01D19/04Foam dispersion or prevention by addition of chemical substances
    • B01D19/0404Foam dispersion or prevention by addition of chemical substances characterised by the nature of the chemical substance
    • B01D19/0409Foam dispersion or prevention by addition of chemical substances characterised by the nature of the chemical substance compounds containing Si-atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK612766AA 1965-12-06 1966-11-25 Fremgangsmåde til fremstilling af farmaceutiske granulater, tabletter eller kapsler indeholdende antacidium, fyldstof og organopolysiloxan. DK116020B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA947065 1965-12-06

Publications (1)

Publication Number Publication Date
DK116020B true DK116020B (da) 1969-12-01

Family

ID=4142389

Family Applications (1)

Application Number Title Priority Date Filing Date
DK612766AA DK116020B (da) 1965-12-06 1966-11-25 Fremgangsmåde til fremstilling af farmaceutiske granulater, tabletter eller kapsler indeholdende antacidium, fyldstof og organopolysiloxan.

Country Status (10)

Country Link
US (1) US3501571A (da)
BE (1) BE690679A (da)
BR (1) BR6685118D0 (da)
DE (1) DE1617800A1 (da)
DK (1) DK116020B (da)
FR (2) FR1515061A (da)
GB (1) GB1129260A (da)
IL (1) IL26885A (da)
NL (1) NL6617127A (da)
SE (1) SE348940B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA885974A (en) * 1968-04-02 1971-11-16 R. Telfer William Ferrous fumarate capsule and preparation
GB1357737A (en) * 1970-10-09 1974-06-26 Arpic Sa Sustained release pharmaceutical compositions
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
JPS51123814A (en) * 1975-04-22 1976-10-28 Shin Etsu Chem Co Ltd A process for preparing gradually releasable solid medicines
US4198390A (en) * 1979-01-31 1980-04-15 Rider Joseph A Simethicone antacid tablet
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
ATE51147T1 (de) * 1982-07-27 1990-04-15 Mylan Pharmaceuticals Inc Verfahren zur herstellung einer kombinierten pharmazeutischen zusammensetzung in einer granulaeren heterogenen dosisform mit erhoehter bioverfuegbarkeit.
US4594243A (en) * 1984-07-25 1986-06-10 Nitto Electric Industrial Co., Ltd. Base composition for medicament and pharmaceutical composition for external medication
GB8710965D0 (en) * 1987-05-08 1987-06-10 Smith Kline French Lab Pharmaceutical compositions
ATE73328T1 (de) * 1987-05-08 1992-03-15 Smith Kline French Lab Pharmazeutische zusammensetzungen.
HU206624B (en) * 1989-01-19 1992-12-28 Steigerwald Arzneimittelwerk Process for producing pharmaceutical composition for treating illnesses of oesophagus and the gastro-intestinal system
US5275822A (en) * 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
USRE35893E (en) * 1989-10-19 1998-09-08 Valentine Enterprises, Inc. Defoaming composition
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
DE3937455A1 (de) * 1989-11-10 1991-05-16 Nordmark Arzneimittel Gmbh Antacidatabletten
FR2705966B1 (fr) * 1993-06-04 1995-08-25 Dow Corning Sa Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
US6399591B1 (en) * 2000-01-19 2002-06-04 Yung-Shin Pharmaceutical Ind. Co., Ltd. Chargeable pharmaceutical tablets
DE102012024434A1 (de) * 2012-12-14 2014-06-18 Regalismons S.A. Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2477080A (en) * 1947-07-15 1949-07-26 Michael Reese Res Foundation Antacid preparation
USRE25205E (en) * 1960-10-10 1962-07-24 Silicone composition for the relief of
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
FR175F (da) * 1964-05-25 1900-01-01

Also Published As

Publication number Publication date
SE348940B (da) 1972-09-18
BR6685118D0 (pt) 1973-12-04
FR1515061A (fr) 1968-03-01
IL26885A (en) 1970-10-30
DE1617800A1 (de) 1971-04-08
NL6617127A (da) 1967-06-07
BE690679A (da) 1967-06-05
FR6885M (da) 1969-04-21
US3501571A (en) 1970-03-17
GB1129260A (en) 1968-10-02

Similar Documents

Publication Publication Date Title
DK112191B (da) Fremgangsmåde til fremstilling af lægemiddelpræparater til oral administration, såsom granulater, tabletter, gelatinekapsler eller drageer.
DK128053B (da) Fremgangsmåde til fremstilling af farmaceutiske kapsler af hydroxyalkylalkylcelluloseethere.
DK116020B (da) Fremgangsmåde til fremstilling af farmaceutiske granulater, tabletter eller kapsler indeholdende antacidium, fyldstof og organopolysiloxan.
DK125207B (da) Fremgangsmåde til fremstilling af dispersionsforstærkede zirconiumprodukter.
DK127923B (da) Fremgangsmåde til fremstilling af maltitol.
NL161055C (nl) Mengkapsule.
DK121462B (da) Beholderenhed til præservering af medikamenter.
DK125957B (da) Fremgangsmåde til fremstilling af mavesaftresistente, tyndtarmopløselige gelatinekapsler.
NL145757B (nl) Farmaceutische capsule.
DK125824B (da) Fremgangsmåde til fremstilling af pressede tabletter.
DK129943B (da) Fremgangsmåde til fremstilling af findelte, ikke-smeltelige og uopløselige melamin-formaldehyd-kondensationsprodukter.
DK128845B (da) Brusetablet eller brusepulver.
DK128878B (da) Blandekapsel til blanding af tandfyldningsmaterialer.
IL30001A0 (en) Phenoxyalkanolamines,processes for their preparation and pharmaceutical compositions containing them
DK128052B (da) Fremgangsmåde til fremstilling af enhedsdoser i fast tilstand af lægemidler under anvendelse af sukker som bærestof.
FI41249C (fi) Nauhamainen pakkaus erillisiin pakkaustiloihin suljettujen kiinteiden, pulverimaisten tai nestemäisten aineiden annoksittain tapahtuvaa irrottamista varten
DK118420B (da) Fremgangsmåde til fremstilling af pressede tabletter.
IL34514A0 (en) 11-desacetoxy-wortmannin,its production and pharmaceutical preparation containing it
DK115670B (da) Udleveringsorgan til granuleret eller pulverformet materiale.
AT312299B (de) Stabilisierte polymere Massen
DK119255B (da) Fremgangsmåde til fremstilling af d- og 1-carnitinchlorid.
DK122708B (da) Fremgangsmåde til fremstilling af farmaceutiske tabletter med langvarig virkning.
DK121922B (da) Fremgangsmåde til fremstilling af formede tabletter.
DK128674B (da) Fremgangsmåde til fremstilling af tabletter indeholdende vandopløselige salte af α-carboxyester-substituerede phenylmethyl-penicilliner eller α-carboxyester-substituerede phenylmethyl-cephalosporiner til oral indgivning.
IS2050A7 (is) Efni afleidd úr acyli og aðferð til að framleiða þau.